Studies eligible for co-enrolment with OPTIMISE II

Effective 8th March 2018

  • Add Aspirin Trial
    • A phase III, double blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non metastatic solid tumours. ISRCTN: 74358648
  • The CIPHER Study
    • UK Cohort study to Investigate the prevention of Parastomal Hernia (Phase B). ISRCTN: 17573805